SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-23-006594
Filing Date
2023-05-15
Accepted
2023-05-15 16:55:46
Documents
54
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ndra_10q.htm   iXBRL 10-Q 520150
2 CERTIFICATION ndra_ex311.htm EX-31.1 11004
3 CERTIFICATION ndra_ex312.htm EX-31.2 10528
4 CERTIFICATION ndra_ex321.htm EX-32.1 4847
  Complete submission text file 0001654954-23-006594.txt   2892022

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ndra-20230331.xsd EX-101.SCH 38559
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ndra-20230331_lab.xml EX-101.LAB 222118
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ndra-20230331_cal.xml EX-101.CAL 33962
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ndra-20230331_pre.xml EX-101.PRE 174316
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ndra-20230331_def.xml EX-101.DEF 80037
48 EXTRACTED XBRL INSTANCE DOCUMENT ndra_10q_htm.xml XML 321079
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

IRS No.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1208
Type: 10-Q | Act: 34 | File No.: 001-37969 | Film No.: 23923810
SIC: 3845 Electromedical & Electrotherapeutic Apparatus